MiMedx will highlight its HydroFix Vaso Shield and AmnioFix Amniotic Membrane Allografts. The HydroFix Vaso Shield is an FDA-approved device designed for vessel protection during anterior vertebral surgery. MiMedx’s AmnioFix is processed from the human amniotic membrane through proprietary technology to produce an implant that is safe, effective and minimally manipulated.
Read the news release about MiMedx’s orthopedic and spine products.
Read other coverage about MiMedx:
– MiMedx Group Acquires Surgical Biologics
– MiMedx Receives FDA Clearance for HydroFix Vaso Shield
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
